| 查看: 282 | 回复: 1 | ||
[求助]
求高人翻译下下
|
|
1. JoA score is a general myelopathy functional measurement. It appears that a large segment of the patient population treated had moderate to severe levels of myelopathy, given their preop score of 10. Please clarify if this score was prospectively obtained at each patient visit, or was it retrospectively reconstructed by the examiners? Given the severity of the myelopathy described, why was no ASIA motor score obtained? Why no health related quality of life score? 2. The authors state that fusion assessed commonly accepted parameters, yet they didn't provide any data on flexion extension radiographs and their interspinous motion, presence of sentinel sign, radiolucency around endplates on lateral imaging and supplemental CT in case of doubtful fusion? 3. In terms of making any claims about fusion by looking at lateral radiographs at a 12 month follow-up I would ask for rephrasing of the title and all pertinent arts of the article to reflect 'early' follow-up. These implants don't really allow assessment of bony in-growth due to their material composition and therefore require ore stringent and longer follow-up to declare 'fusion'. |
回复此楼» 猜你喜欢
求调剂
已经有3人回复
-
285求调剂
已经有6人回复
-
材料求调剂
已经有3人回复
-
288求调剂
已经有6人回复
-
复试调剂
已经有12人回复
-
计算机11408，286分求调剂
已经有3人回复
-
材料专硕322分
已经有8人回复
-
一志愿上海海洋大学083200食品学硕，求调剂，接受其他专业083200
已经有5人回复
-
081200-11408-276学硕求调剂
已经有5人回复
-
材料调剂
已经有10人回复
2楼2012-10-12 17:04:58
